Genenta Science S.p.A. (GNTA)
USD 5.15
(-2.83%)
USD 5.15
(-2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 41.58 Thousand | 6029.42 | 5084.02 | 1770.22 | - |
| Gross Profit | -41.58 Thousand | -6029.42 | -5084.02 | -1770.22 | - |
| Operating Expenses | 11.73 Million | 11.04 Million | 5.53 Million | 5.59 Million | 4.62 Million |
| Selling, General and Administrative Expenses | 5.25 Million | 5.7 Million | 2.29 Million | 901.76 Thousand | 921.52 Thousand |
| Research and Development Expenses | 6.47 Million | 5.33 Million | 3.39 Million | 4.68 Million | 3.7 Million |
| Other Expenses | - | 242.55 Thousand | -150 Thousand | 5966.00 | 36.33 Thousand |
| Cost and Expenses | 11.73 Million | 11.04 Million | 5.53 Million | 5.59 Million | 4.62 Million |
| Operating Income | -11.73 Million | -11.04 Million | -5.68 Million | -5.59 Million | -4.62 Million |
| Interest Expense | - | - | 11.71 Thousand | 7754.00 | 9552.00 |
| Income Tax Expense | - | -4.85 Million | 31.37 Thousand | 13.72 Thousand | 9552.00 |
| Earnings before Tax | -11.64 Million | -8.47 Million | -5.52 Million | -5.59 Million | -4.59 Million |
| Net Income | -11.64 Million | -3.62 Million | -5.56 Million | -5.6 Million | -4.6 Million |
| Earnings Per Share Basic | -0.64 | -0.20 | -0.31 | -0.31 | -0.25 |
| Earnings Per Share Diluted | -0.64 | -0.20 | -0.31 | -0.31 | -0.25 |
| Weighted Average Shares Outstanding | 18.21 Million | 18.21 Million | 18.21 Million | 18.12 Million | 18.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.21 Million | 18.21 Million | 18.21 Million | 18.12 Million | 18.12 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -11.69 Million | -11.03 Million | -5.68 Million | -5.58 Million | - |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 41.58 Thousand | 20.88 Thousand | - | 20.94 Thousand | - | 6029.42 |
| Gross Profit | -41.58 Thousand | -20.88 Thousand | - | -20.94 Thousand | - | -6029.42 |
| Operating Expenses | 11.45 Million | 2466.38 | 2501.25 | 6.71 Million | 3476.11 | 11.04 Million |
| Selling, General and Administrative Expenses | - | 1190.06 | 1190.06 | 2.83 Million | 1439.19 | - |
| Research and Development Expenses | - | 1276.32 | 1276.32 | 3.88 Million | 1960.90 | - |
| Other Expenses | - | - | - | - | - | 242.55 Thousand |
| Cost and Expenses | 11.49 Million | 2466.38 | 2501.25 | 6.73 Million | 3476.11 | 11.04 Million |
| Operating Income | -11.49 Million | -2466.38 | -2466.38 | -6.73 Million | -3400.09 | -11.04 Million |
| Interest Expense | - | - | - | - | - | -2.56 Million |
| Income Tax Expense | 4.00 | -1.00 | - | 3.00 | - | -4.85 Million |
| Earnings before Tax | -11.4 Million | -2443.12 | -2443.12 | -6.69 Million | -3379.61 | -8.47 Million |
| Net Income | -11.4 Million | -2443.12 | -2443.12 | -6.69 Million | -3379.61 | -3.62 Million |
| Earnings Per Share Basic | - | -0.13 | -0.13 | -0.37 | -0.19 | - |
| Earnings Per Share Diluted | - | -0.13 | -0.13 | -0.37 | -0.19 | - |
| Weighted Average Shares Outstanding | 18.21 Million | 18.21 Thousand | 18.21 Thousand | 18.21 Million | 18.21 Thousand | 18.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.21 Million | 18.21 Thousand | 18.21 Thousand | 18.21 Million | 18.21 Thousand | 18.21 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -2455.73 | -2455.73 | -6.71 Million | -3389.52 | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
TTZ
600601
THANI
TIG
002728
ADEN